How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?
Simon Bailey(Newcastle University), Uri Tabori(Universität Hamburg), Jeannette Parkes(University of Cape Town), Anthony Figaji(University of Antwerp), Rosdali Díaz Coronado(Instituto Nacional de Enfermedades Neoplásicas), Girish Chinnaswamy(Tata Memorial Hospital), Alan Davidson(Red Cross War Memorial Children's Hospital), Gilles Vassal(Université Paris-Saclay), Éric Bouffet(Hospital for Sick Children), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Nisreen Amayiri(King Hussein Cancer Center), Shridar Epari(Homi Bhabha National Institute)
Cited by 31
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.5k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853